Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of JWK002 in patients with X-linked retinoschisis
CTR20252527Phase 2Active
- Sponsor
- King-Viko
- Start
- Jul 2025
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of jwk002 in X-linked retinoschisis (XLRS), sponsored by King-Viko. Started Jul 2025; status: active.
02
Drugs
jwk002
03
Conditions
X-linked retinoschisis (XLRS)
Beyond the preview
Go deeper on CTR20252527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252527.